Berliner Tageszeitung - Tunisia detains anti-president MP: lawyer

NYSE - LSE

RIO	0.5%	105.88	$
NGG	-0.27%	81.62	$
BTI	-1.89%	61.165	$
CMSD	0.45%	22.36	$
GSK	-1.56%	52.225	$
RYCEF	2.63%	17.5	$
BCE	-0.96%	24.0455	$
BCC	0.97%	71.84	$
BP	-2.6%	41.695	$
JRI	0.81%	12.77	$
VOD	-3.29%	15.035	$
CMSC	0.04%	22.34	$
RBGPF	0%	60.72	$
AZN	-0.9%	177.152	$
RELX	-2.85%	32.805	$

Tunisia detains anti-president MP: lawyer

BOULEVARD 21.01.2023

Plainclothes security officers in Tunisia detained a prominent critic of President Kais Saied in the early hours of Saturday after a military court ruling, his lawyer told AFP.

Text size:

Seifeddine Makhlouf had been found guilty of insulting police during a standoff at Tunis airport in March 2021.

Makhlouf, head of Islamist nationalist party Al-Karama, shouted "down with the coup" and "long live Tunisia" before being bundled into a car, according to a Facebook video posted by the lawyer.

Rights groups say military trials of civilians have become increasingly common in Tunisia since a power grab by Saied.

Tunis military appeals court on Friday sentenced Makhlouf to 14 months in prison with immediate effect, his lawyer Ines Harrath told AFP.

A court had initially sentenced him to five months' jail.

"Around 25 officers in plainclothes surrounded his house at 11:00 PM," Harrath said.

After a two-hour standoff, "they came into the house and he left with them."

Makhlouf has been a prominent critic of Saied, who in July 2021 froze parliament and seized far-reaching executive powers in what critics have called a "coup" and an attack on the only democracy to have emerged from the Arab Spring uprisings more than a decade ago.

Saied later took control of the judiciary and pushed through a new constitution giving his office almost unlimited powers.

Makhlouf in March 2021 led a group of Al-Karama MPs to Tunis airport in a bid to force authorities to allow a woman to travel, sparking the standoff that was widely shared online. She had been under a travel ban.

The court on Friday also sentenced several other members of Karama to shorter prison sentences, but they were not immediately detained.

Makhlouf also received a year-long suspended prison sentence last February for "attacking the dignity of the army", after losing his parliamentary immunity following Saied's power grab.

He was also banned from working as a lawyer for five years.

A military court upheld the one-year prison sentence in June but his lawyer in that case said he would appeal.

"Putting civilians on trial in military courts is an attack on freedoms," Harrath said. "This case is related to the defendants' positions on Kais Saied."

A. Bogdanow--BTZ

Featured

'They want to destroy us': Shock and anger as Russian attack sets Kyiv cathedral ablaze

Father Makariy, a high-ranking clergyman at Kyiv's Pechersk Lavra monastery complex, was woken at around 5:00 am with a huge roar -- the cathedral at the heart of one of Orthodox Christianity's most important sites had been set on fire in a Russian attack.

Burnt-out Indonesians beat the blues with children's games

Flushed and sweating, 31-year-old Annisa Enggracia Fidel runs back and forth to defend her fort from invaders -- hundreds of fellow adults all beating the blues by playing a nostalgic Indonesian children's game.

Greek fishermen struggle to keep up with pufferfish invaders

On his fishing boat moored in the Greek port of Ierapetra in southwestern Crete, Alexis Charlambakis pries open the mouth of a freshly-caught pufferfish to reveal two massive teeth on each jaw.

BioNxt Engages Business Development & Licensing Advisors for Commercialization of Patented Sublingual Cladribine ODF

VANCOUVER, BC / ACCESS Newswire / June 15, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that it has commenced work with a Business Development & Licensing ("BD&L") specialist advisor to support the commercialization and partnering strategy for BNT23001, the Company's patented proprietary sublingual Cladribine orally dissolvable film ("ODF") formulation for the treatment of multiple sclerosis ("MS").